Hypercalcemia Newswire

Hypercalcemia Newswire

Comprehensive Real-Time News Feed for Hypercalcemia.

Results 1 - 15 of 15 in Hypercalcemia

  1. Global Outlook for Calcitonin Salmon Market by Key Trends and Analysis 2026Read the original story w/Photo

    Jul 28, 2017 | SBWire

    ... available brands for calcitonin salmon. Calcitonin salmon is used for indications such as osteoporosis, hypercalcemia, Paget's disease of bone, and other bone related diseases. The global calcitonin salmon market is driven by increasing number of ...

    Comment?

  2. Opko Health Announces KDIGO Clinical Practice Guideline Update On CKD-MBDRead the original story

    Jun 21, 2017 | BioSpace

    The update amends the 2009 KDIGO Clinical Practice Guideline and presents revised positions on current standards of care for the treatment of secondary hyperparathyroidism in patients with CKD stages 3 or 4: Calcitriol and vitamin D analogs : These therapies are no longer suggested for routine use and should be reserved for patients with stage 4 or 5 CKD with severe and progressive hyperparathyroidism. The guideline notes that recent randomized clinical trials of calcitriol and its analogs failed to demonstrate improvements in outcomes but demonstrated increased risk of hypercalcemia, leading KDIGO to conclude that the risk-benefit ratio was no longer favorable for routine usage in patients with stage 3 or 4 CKD.

    Comment?

  3. Opko Health Provides Commercial Update For RAYALDEERead the original story

    Jun 4, 2017 | BioSpace

    ... 5 chronic kidney disease or end-stage renal disease on dialysis.2 Potential side effects of RAYALDEE include hypercalcemia (elevated serum calcium), which can also lead to digitalis toxicity, and adynamic bone disease with subsequent increased risk ...

    Comment?

  4. How to Make Big Bucks Flipping DrugsRead the original story

    Nov 2, 2016 | P&T Community

    ... In another example, Sebela Pharmaceuticals bought Miacalcin (calcitonin salmon), an injectable drug for hypercalcemia, from Novartis in August 2014. During the next eight months, the price of the drug rose more than 2,800% to $1,987 per vial from ...

    Comment?

  5. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story w/Photo

    May 5, 2017 | Business Wire

    ... at the company's annual meeting of stockholders. )--Technavio market research analysts forecast the global hypercalcemia treatment market to grow at a CAGR of more than 5% during the forecast period, according to their lates... )--National Beverage ...

    Comment?

  6. Global Hypercalcemia Treatment Market 2017-2021: Market Insights and Key Drivers by TechnavioRead the original story w/Photo

    May 5, 2017 | Business Wire

    According to Sapna Jha, a lead analyst at Technavio for health and wellness research, "The global hypercalcemia treatment market is expected to benefit from the growing incidence of chronic conditions that cause spasticity and spasms. This has driven vendors to conduct R&D, to develop drugs which will help to drive market growth."

    Comment?

  7. Global Hypercalcemia Treatment Market 2017-2021; New Report LaunchedRead the original story w/Photo

    Apr 27, 2017 | SBWire

    Hypercalcemia is a condition in which the calcium level in the blood is above normal. Too much calcium in the blood can weaken the bones, create stones in the kidneys, and interfere with the functioning of the heart and the brain.

    Comment?

  8. Hypercalcemia Treatment 2017 Global Market Expected to Grow at CAGR Of 5.44% and Forecast To 2021Read the original story w/Photo

    Apr 26, 2017 | World News Report

    About Hypercalcemia Treatment Hypercalcemia is a condition in which the calcium level in the blood is above normal. Too much calcium in the blood can weaken the bones, create stones in the kidneys, and interfere with the functioning of the heart and the brain.

    Comment?

  9. Hypercalcemia Pharmacotherapy: A ReviewRead the original story w/Photo

    Apr 10, 2017 | Pharmacy Times

    ... include oncology, education, and infectious diseases. Although there are several conditions that can lead to hypercalcemia, most (about 90%)1 are caused by either hyperparathyroidism or malignancy (specifically lung cancer, breast cancer, and ...

    Comment?

  10. Low-quality Cuban cancer drugs ravaging cancer patients in VenezuelaRead the original story w/Photo

    Apr 7, 2017 | Babalu Blog

    ... access to, the women have complaints. They particularly mention Zometa (zoledronic acid), used for treating hypercalcemia in cancer patients with tumors. "Zometa is a bone protector and [yet] whoever uses the Cuban medication spends up to fifteen ...

    Comment?

  11. Calcitonin Salmon Market: 2026 Forecast & Future Industry TrendsRead the original story w/Photo

    Mar 15, 2017 | SBWire

    ... available brands for calcitonin salmon. Calcitonin salmon is used for indications such as osteoporosis, hypercalcemia, Paget's disease of bone, and other bone related diseases. Browse Market Research Report @ ...

    Comment?

  12. Microbial Food Cultures Market To Make Great Impact In Near Future by 2025Read the original story w/Photo

    Feb 23, 2017 | PR-inside.com

    ... Press: [email protected] Website: www.futuremarketinsights.com Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in [..] Tea is a second most consumed drink after water. All ...

    Comment?

  13. Calcitonin Salmon Market - Global Market Snapshot by 2026Read the original story w/Photo

    Feb 21, 2017 | SBWire

    ... available brands for calcitonin salmon. Calcitonin salmon is used for indications such as osteoporosis, hypercalcemia, Paget's disease of bone, and other bone related diseases. The global calcitonin salmon market is driven by increasing number of ...

    Comment?

  14. $25,230 Million Hypercalcemia Treatment Market: Global Industry...Read the original story

    Feb 1, 2017 | Customer Interaction Solutions

    Global hypercalcemia treatment market revenue is projected to expand at a CAGR of 11.2% during forecast period 2016-2026, and a reach a value of US$ 25,230.2 Mn by the end of 2026. Early diagnosis of hypercalcemia by hydration and treatment with agents - to decrease serum calcium concentrations - also known as hypocalcemic drugs can produce symptomatic improvements within three to five days.

    Comment?

  15. Hypercalcemia Market Overview 2016 by Country, GeographyRead the original story

    Jan 30, 2017 | Emailwire.com

    ReportsWeb.com published 'Hypercalcemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016'from its database. The report covers the market landscape and its growth prospects over the coming years.

    Comment?